Sandoz Group AG (SDZ) - Total Assets
Based on the latest financial reports, Sandoz Group AG (SDZ) holds total assets worth CHF21.61 Billion CHF as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sandoz Group AG - Total Assets Trend (2020–2024)
This chart illustrates how Sandoz Group AG's total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sandoz Group AG - Asset Composition Analysis
Current Asset Composition (December 2024)
Sandoz Group AG's total assets of CHF21.61 Billion consist of 39.2% current assets and 60.8% non-current assets.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF1.19 Billion | 6.0% |
| Accounts Receivable | CHF3.15 Billion | 15.8% |
| Inventory | CHF2.80 Billion | 14.1% |
| Property, Plant & Equipment | CHF1.99 Billion | 10.0% |
| Intangible Assets | CHF1.48 Billion | 7.4% |
| Goodwill | CHF7.47 Billion | 37.5% |
Asset Composition Trend (2020–2024)
This chart illustrates how Sandoz Group AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sandoz Group AG's current assets represent 39.2% of total assets in 2024, an increase from 31.4% in 2020.
- Cash Position: Cash and equivalents constituted 6.0% of total assets in 2024, up from 0.2% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 44.0% of total assets, unchanged from 44.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 37.5% of total assets.
Sandoz Group AG Competitors by Total Assets
Key competitors of Sandoz Group AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩642.17 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
Sandoz Group AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.29 | 1.22 | 0.62 |
| Quick Ratio | 0.82 | 0.74 | 0.36 |
| Cash Ratio | 0.21 | 0.12 | 0.00 |
| Working Capital | CHF1.90 Billion | CHF1.32 Billion | CHF-3.10 Billion |
Sandoz Group AG - Advanced Valuation Insights
This section examines the relationship between Sandoz Group AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.22 |
| Latest Market Cap to Assets Ratio | 1.48 |
| Asset Growth Rate (YoY) | 2.5% |
| Total Assets | CHF19.91 Billion |
| Market Capitalization | $29.43 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Sandoz Group AG's assets above their book value (1.48x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Sandoz Group AG's assets grew by 2.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Sandoz Group AG (2020–2024)
The table below shows the annual total assets of Sandoz Group AG from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CHF19.91 Billion | +2.45% |
| 2023-12-31 | CHF19.43 Billion | +19429900.00% |
| 2022-12-31 | CHF100.00K | -100.00% |
| 2021-12-31 | CHF15.98 Billion | +0.76% |
| 2020-12-31 | CHF15.86 Billion | -- |
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage f… Read more